DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+6.5%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$308M
AUM Growth
+$308M
(-11%)
Cap. Flow
-$26.2M
Cap. Flow
% of AUM
-8.51%
Top 10 Holdings %
Top 10 Hldgs %
52.97%
Holding
98
New
10
Increased
19
Reduced
20
Closed
18
Top Buys
| 1 |
IDEAYA Biosciences
IDYA
|
$4.17M |
| 2 |
Arcturus Therapeutics
ARCT
|
$3.46M |
| 3 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$2.6M |
| 4 |
Ascendis Pharma
ASND
|
$2.31M |
| 5 |
89bio
ETNB
|
$2.31M |
Top Sells
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$12.7M |
| 2 |
Kura Oncology
KURA
|
$7.82M |
| 3 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$3.85M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$3.8M |
| 5 |
Compugen
CGEN
|
$3.7M |
Sector Composition
| 1 | Healthcare | 83.1% |
